Much of the remaining IPD burden is due to serotypes included in PCV15 and PCV20. The inclusion of these next generation PCVs into existing pediatric NIPs may further reduce the incidence of childhood IPD.
No takes yet. Share an insight, caveat, or question.
Grant et al. (2022) studied this question.